Point of Care Diagnostics Market By Product: Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others; By End User: Hospital Bedside, Physician’s Office Lab, Urgent Care & Ret

Point of Care Diagnostics Market By Product: Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others; By End User: Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-testing, Regional Outlook - Global Forecast up to 2030


We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary methods for qualitative market assessments and market segmentation are top-down and bottom-up techniques. We take pride in our ability to use data triangulation to examine the market from three key angles: primary data mining, a specific statistical model and framework, and primary source data validation.

We carefully choose our original raw market data for analysis from a vast collection of data that has been compiled in our repository, as well as from sets of trustworthy and validated websites, analyst evaluations, news announcements, whitepapers, and reputable paid databases. Trade journals and in-depth surveys are used to collaborate on technical data and trends. Verified sources are used to assess pricing trends and market dynamics.

We use particular data simulation models to get our market estimates and forecasts. These models are developed and tailored to match the unique needs of every study. They are nimble and adaptable. For the most part, we use a joint combination of technological analysis, economic tools, domain experience, and economic techniques to forecast and estimate the market. In general, we favor using a bottom-up method to assess the worldwide market and calculate the anticipated rate of growth.

To verify our hypotheses and the results we have gotten, we carry out in-depth primary interviews, which include phone conversations, in-person discussions, and targeted group discussions. Extensive primary research has been conducted to verify our figures and forecast. These interviews also provide us with an objective view of the market, important information on companies operating in various markets, and up-to-date business scenarios.

Point of Care Diagnostics Market based on Product:
  • Blood Glucose Monitoring
  • Infectious Disease Testing
  • Cardiometabolic Disease Testing
  • Pregnancy & Fertility Testing
  • Hematology Testing
  • Others
Point of Care Diagnostics Market based on Sample:
  • Blood
  • Nasal and Oropharyngeal Swabs
  • Urine
  • Others
Point of Care Diagnostics Market based on End User:
  • Hospital Bedside
  • Physician’s Office Lab
  • Urgent Care & Retail Clinics
  • Home & Self testing
Point of Care Diagnostics Market based on Geography:
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Real-time and on-site testing for diabetes has been made possible by technology improvements, which has also aided this market segment. The precision and effectiveness of glucose testing at the point of care have improved thanks to these advancements. Furthermore, the growing demand for these goods has been fueled by the growing popularity of wearable and portable glucose meters. These gadgets are appealing choices for both patients and healthcare professionals because of their quick outcomes, simplicity of use, and reduced operating costs.

The market's revenue share was controlled by the clinics sector. This is explained by the growing number of PoC diagnostics laboratory centers opening up within clinics, which has enhanced patient-centered treatment while cutting expenses. Better patient outcomes have resulted from the decentralization of healthcare services brought about by these specialized centers.

Testing operations in hospitals are increasingly being outsourced, which improves test efficiency and lowers personnel expenses. Hospitals use outside resources to complete some diagnostic tests so they can concentrate on their primary duties and optimize their operations. Positive regulations like those found in the CHIP Reauthorization Act and Medicare have also helped the PoC diagnostics industry sector expand. These regulations have produced a favorable atmosphere for implementing and growing PoC testing in various healthcare settings.

Over the course of the projection period, the residential category has grown at the fastest rate. This is explained by the growing use of PoC testing in older and pediatric populations. The geriatric population is expanding and raising life expectancy as a result of lower birth rates in emerging nations and easier access to healthcare. As a result, chronic illnesses like diabetes, memory loss, and heart problems linked to lifestyle choices are more common. PoC testing at home provides these people with accessibility and convenience, which fuels the expansion of the market.
  • This report illustrates the most vital attributes of the Point of Care Diagnostics Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Point of Care Diagnostics Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Point of Care Diagnostics Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Point of Care Diagnostics Market.


1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Blood Glucose Monitoring
5.3. Infectious Disease Testing
5.4. Cardiometabolic Disease Testing
5.5. Pregnancy & Fertility Testing
5.6. Hematology Testing
5.7. Others
6. Sample: Market Size & Analysis
6.1. Overview
6.2. Blood
6.3. Nasal and Oropharyngeal Swabs
6.4. Urine
6.5. Others
7. End User: Market Size & Analysis
7.1. Overview
7.2. Hospital Bedside
7.3. Physician’s Office Lab
7.4. Urgent Care & Retail Clinics
7.5. Home & Self testing
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. CARDINAL HEALTH INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. TRINITY BIOTECH
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. BIO-RAD LABORATORIES INC.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. THERMO FISHER SCIENTIFIC INC.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. QUEST DIAGNOSTICS INCORPORATED
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. QUIDEL CORPORATION
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. ABBOTT LABORATORIES
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. MESA BIOTECH
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. F. HOFFMANN-LA ROCHE LTD
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. CEPHEID
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings